BEXXAR - tositumomab I-131
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC| Field | Value |
|---|---|
| NDC Code: | 0007-3262 |
| Proprietary Name: | BEXXAR |
| Suffix: | THERAPEUTIC |
| Non-Proprietary Name: | tositumomab I-131 |
| Dosage Form: | INJECTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 15-07-2009 |
| Category Name: | BLA |
| Application Number: | BLA125011 |
| Labeler: | GLAXOSMITHKLINE LLC |
| Substance Name: | TOSITUMOMAB I-131 |
| Active Numerator Strength: | 5.6 |
| Active Ingredient Unit: | mCi/mL |
| Pharm Classes: | CD20-directed Antibody Interactions [MoA],CD20-directed Radiotherapeutic Antibody [EPC],Radiopharmaceutical Activity [MoA] |
| DEA Schedule: |